Seok Jin Nam
0000-0003-1072-8954
Publication & Citation Trends
Publications
0 total
Vitamin/mineral and non-vitamin/non-mineral supplement use of breast cancer survivors in Korea
Cited by 0
Semantic Scholar
A Practical Immunohistochemistry-Based Model for Predicting Pathologic Complete Response in Estrogen Receptor-Strong Positive and HER2-Negative Breast Cancer Running title: IHC-Based Prediction Model of pCR in ER-Positive HER2-Negative Breast Cancer.
Cited by 0
Semantic Scholar
Independent prognostic value of the gene-only BCT Score compared with the 21-gene recurrence score in ER+/HER2− early breast cancer
Cited by 0
Semantic Scholar
Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion
Cited by 2
Semantic Scholar
Axillary Surgery in Breast Cancer: Evidence-Based De-escalation Across Upfront and Post-Neoadjuvant Settings
Cited by 0
Semantic Scholar
Association between asymptomatic detection of distant metastases and survival in breast cancer: a retrospective cohort study
Cited by 0
Semantic Scholar
Clinical Outcomes of Lobular Carcinoma In Situ : Risk of Invasive Cancer Development
Cited by 0
Semantic Scholar
Perceived financial toxicity after active treatment and its association with clinical outcomes among breast cancer survivors: A prospective cohort study
Cited by 0
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(287)
Breast Lesions and Carcinomas
(161)
HER2/EGFR in Cancer Research
(80)
Breast Implant and Reconstruction
(61)
BRCA gene mutations in cancer
(56)
Affiliations
Roche (Switzerland)
Novartis (Switzerland)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Fox Chase Cancer Center
Yahoo (United Kingdom)